Minimally invasive cancer surgery improves patient survival rates through less perioperative immunosuppression
- 31 December 2007
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 68 (6) , 1328-1332
- https://doi.org/10.1016/j.mehy.2006.09.063
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- T cells targeted against a single minor histocompatibility antigen can cure solid tumorsNature Medicine, 2005
- Gene Expression Changes in Leukocytes During Cardiopulmonary Bypass Are Dependent on Circuit CoatingCirculation, 2005
- Long-term Survival After Videothoracoscopic Lobectomy for Stage I Lung CancerChest, 2004
- Cytokine gene expression in monocytes of patients undergoing cardiopulmonary bypass surgery evaluated by real‐time PCRJournal of Cellular and Molecular Medicine, 2003
- Long-term outcomes following VATS lobectomy for non-small cell bronchogenic carcinomaEuropean Journal of Cardio-Thoracic Surgery, 2003
- Higher colon cancer tumor proliferative index and lower tumor cell death rate in mice undergoing laparotomy versus insufflationSurgical Endoscopy, 2001
- Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general populationThe Lancet, 2000
- Tumor proliferative index is higher in mice undergoing laparotomy vs. CO2 pneumoperitoneumDiseases of the Colon & Rectum, 1999
- Increased tumor establishment and growth after open vs laparoscopic surgery in mice may be related to differences in postoperative T-cell function.Surgical Endoscopy, 1999
- Postoperative immune function varies inversely with the degree of surgical trauma in a murine modelSurgical Endoscopy, 1997